help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mall, M.
Right arrow Articles by Kunzelmann, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mall, M.
Right arrow Articles by Kunzelmann, K.
Am. J. Respir. Cell Mol. Biol., Volume 23, Number 3, September 2000 283-289

Role of KVLQT1 in Cyclic Adenosine Monophosphate-Mediated Clminus Secretion in Human Airway Epithelia

Marcus Mall, Andreas Wissner, Rainer Schreiber, Joachim Kuehr, Hans H. Seydewitz, Matthias Brandis, Rainer Greger, and Karl Kunzelmann

Universitäts-Kinderklinik and Physiologisches Institut, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany; and Department of Physiology & Pharmacology, University of Queensland, Brisbane, Australia


    Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Ion transport defects underlying cystic fibrosis (CF) lung disease are characterized by impaired cyclic adenosine monophosphate (cAMP)-dependent Cl- conductance. Activation of Cl- secretion in airways depends on simultaneous activation of luminal Cl- channels and basolateral K+ channels. We determined the role of basolateral K+ conductance in cAMP- dependent Cl- secretion in native human airway epithelium obtained from non-CF and CF patients. CF tissues showed typical alterations of short-circuit currents with enhanced amiloride-sensitive Na+ conductance and defective cAMP-mediated Cl- conductance. In non-CF tissues, Cl- secretion was significantly inhibited by the chromanol 293B (10 µmol/liter), a specific inhibitor of KVLQT1 K+ channels. Inhibition was increased after cAMP-dependent stimulation. Similar effects were obtained with Ba2+ (5 mmol/liter). In patch-clamp experiments with a human bronchial epithelial cell line, stimulation with forskolin (10 µmol/liter) simultaneously activated Cl- and K+ conductance. The K+ conductance was reversibly inhibited by Ba2+ and 293B. Analysis of reverse-transcribed messenger RNA from non-CF and CF airways showed expression of human KVLQT1. We conclude that the K+ channel KVLQT1 is important in maintaining cAMP-dependent Cl- secretion in human airways. Activation of KVLQT1 in CF airways in parallel with stimulation of residual CF transmembrane conductance regulator Cl- channel activity or alternative Cl- channels could help to circumvent the secretory defect.


    Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Cl- secretion in airway epithelial cells requires parallel activation of luminal Cl- channels and basolateral K+ channels. Whereas Cl- channels are required for exit of Cl- to the luminal side of the epithelium, K+ channels are required for recycling of K+ via the basolateral membrane (1, 2). These K+ channels hyperpolarize the cell membrane voltage and thus maintain transepithelial electrolyte secretion. CF is one of the most common autosomal recessive diseases, characterized by a defect of cyclic adenosine monophosphate (cAMP)-dependent Cl- conductance in the apical membrane of airway epithelia. Thus, identification of basolateral K+ channels involved in activation of cAMP-dependent Cl- secretion could help to develop new pharmacologic strategies to circumvent the cystic fibrosis (CF) defect. So far, at least two different types of K+ channels have been detected in the basolateral membrane of secretory epithelial cells in previous studies. In colonic epithelia of mouse, rat, and human, Ca2+- and cAMP-dependent K+ conductances have been described (3). These K+ conductances are formed by separate individual K+channel entities. This has been demonstrated by the differential effects of K+ channel inhibitors on both cAMP- and Ca2+-activated K+ conductances. Typically, Ca2+-activated K+ conductance is inhibited by the compound clotrimazole, whereas cAMP-dependent K+ conductance is inhibited by the chromanol 293B (7, 8). Additional evidence for different populations of basolateral K+ channels came from patch-clamp experiments on isolated colonic crypt cells. According to these studies, Ca2+-activated K+ channels are of larger single-channel amplitude and can be resolved as single-channel currents, whereas cAMP-dependent K+ channels are of very small single-channel conductance and need to be analyzed by noise analysis (4 - 6, 9).

Both types of K+ conductance have been identified on the molecular level. The Ca2+-activated K+ channel was shown recently to be formed by a member of the hSK K+ channel family (10). This channel has been detected in human and rat colonic crypt cells (11). When expressed in Xenopus oocytes, a large Ca2+-activated K+ conductance is formed that is inhibited by clotrimazole and activated by the compound 1-EBIO (6, 7, 11, 12). The same compound, clotrimazole, also inhibits Ca2+-activated K+ channels and short-circuit currents in the colonic epithelium. The basolateral cAMP-activated K+ channel is blocked by the chromanol compound 293B with a concentration for half-maximal inhibition (IC50) below 1 µM (8). The very same compound has been found to block KVLQT1 K+ channels expressed in Xenopus oocytes (13, 14). KVLQT1 (KCNQ1) is a voltage-gated K+ channel, cloned initially from heart cells where it is essential for repolarization of the heart action potential. When the channel is mutated this process is defective, as in certain forms of cardiac arrhythmia. Other members of this type of K+ channel were detected in the vestibular organ, brain, and sensory outer hair cells (15- 18). Cloning and expression of KVLQT1 in colonic epithelial cells was shown in a recent study (19). These findings prompted us to assume a similar K+ channel in airway epithelial cells. We now deliver data indicating that in fact KVLQT1 is forming the basolateral cAMP-activated K+ conductance in human airway epithelia. According to our data, parallel activation of KVLQT1 and alternative Cl- channels or residual CF transmembrane conductance regulator (CFTR) Cl- channel activity may help to restore the secretory defect in CF airways.

    Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Cell Culture

Cells from the immortalized human bronchial epithelial cell line 16HBE14O-(HBE) (kindly provided by Dr. D. Gruenert, University of California at San Francisco, San Francisco, CA) (20) were grown on plastic tissue-culture dishes and kept in an atmosphere of 5% CO2/95% air in modified Eagle's medium containing (per liter) 5 mmol D-glucose, 20 mmol D-galactose, 2 mmol L-glutamine, 100 g fetal calf serum, 100 mg streptomycin, and 10,000 U penicillin.

Patch-Clamp Experiments

The culture dishes were mounted on the stage of an inverted microscope (Axiovert 10; Zeiss, Obernochen, Germany) and kept at 37°C. The bath perfusion rate was 20 ml/min, corresponding to a bath exchange rate of twice per second. The standard bath solution contained (in mmol/liter): NaCl 145, K2HPO4 1.6, KH2PO4 0.4, CaCl2 1.3, MgCl2 1.0, and D-glucose 5. The pH was adjusted to 7.4. A flowing KCl electrode served as a reference and appropriate corrections for liquid junction potentials were made. The fast whole-cell (WC) patch-clamp method was used (21). The patch pipettes had an input resistance between 2 and 4 MOmega and were filled with a solution containing (in mmol/liter): KCl 30, K-gluconate 95, NaH2PO4 1.2, Na2HPO4 4.8, ethyleneglycol-bis- (beta -aminoethyl ether)-N,N'-tetraacetic acid 1, CaCl2 0.7, MgCl 1.3, D-glucose 5, adenosine triphosphate 1. The pH was adjusted to 7.2 and the Ca2+ activity of this solution was 0.1 µmol/liter. The access conductance (GA) was measured by applying sinus command voltages (800 Hz) in each experiment and was between 30 and 120 nS. Appropriate corrections for the measurement of GA were made to obtain accurate WC conductance readings. Currents and voltages were recorded with a patch-clamp amplifier (Fröbe/Busch, this institute) and continuously displayed by a pen recorder. The membrane voltage (Vm) of the cells was recorded continuously using the current clamp mode of the patch-clamp amplifier and the WC current (I) was measured at regular intervals by clamping the membrane voltage (Vc) to ± 30 mV in steps of 10 mV. The WC conductance (Gm) was calculated according to Ohm's law from the measured I and Vc.

Ussing Chamber Experiments

Freshly excised nasal tissues were obtained from 20 non-CF individuals after surgery for plastic reconstruction or sleep apnea syndrome (15 subjects) or nasal polyps (5 subjects) and from 10 CF patients after polypectomy (Professor R. Laszig, ENT Clinic, University Hospital Freiburg; and Professor G. Münker, ENT Clinic University Hospital Ludwigshafen). The tissues were immediately put into ice-cold buffer solution with the following composition (in mmol/liter): NaCl 127, KCl 5, Glucose 5, MgCl2 1, Na-Pyruvate 5, N-2-hydroxyethylpiperazine-N'-ethane sulfonic acid 10, and CaCl2 1.25; and albumin 10 g/liter. A thin layer of respiratory epithelium was dissected from the polyp and mounted into a modified Ussing chamber as described previously (3). The open tissue area of the chamber was minimized to 0.95 mm2, allowing for stable measurements of small pieces of native respiratory tissue. The luminal and basolateral baths were perfused continuously at a rate of 15 ml/min (chamber volume, 2 ml) allowing us to examine the effect of K+ channel blockers on Cl- secretion in the absence and presence of cAMP stimulation in a paired fashion. The bath solution had the following composition (in mmol/liter): NaCl 145, KH2PO4 0.4, K2HPO4 1.6, glucose 5, MgCl2 1, Ca-gluconat 1.3. The pH was adjusted to 7.4. Bath solutions were heated by water jackets and all experiments were carried out at 37°C. Ussing chamber measurements were carried out under open-circuit conditions. Transepithelial resistance (Rte) was determined by applying short (1 s) current pulses (Delta I = 0.5 µA) and by recording the corresponding changes in transepithelial voltage (Vte), or Delta Vte, as well as the basal Vte continuously. Values for the Vte were referred to the serosal side of the epithelium. The voltage deflections obtained with the empty chamber (Delta Vte) were subtracted from those obtained in the presence of the mucosa. Rte was calculated according to Ohms law (RteDelta Vte - Delta Vte)/Delta I). The equivalent short-circuit current (Isc) was determined from Vte and Rte, i.e., Isc = Vte/Rte. After mounting the tissues in the Ussing chamber, an equilibration period of 60 min was allowed for stabilization of basal Vte and Rte. Then amiloride (10 µmol/liter; luminal side) was applied to block electrogenic Na+ absorption. cAMP-dependent Cl- secretion was activated by adding isobutylmethylxanthine (IBMX) and forskolin (100/1 µmol/ liter; both sides). The K+ channel blockers Ba2+ (5 mmol/liter) and the chromanol 293B (0.01 to 100 µmol/liter) were added to the basolateral side of the epithelium.

RNA Isolation and Reverse Transcriptase/Polymerase Chain Reaction

Total RNA was isolated from the mucosal layer of freshly excised non-CF and CF nasal polyps and from HBE cells using RNeasy spin columns (Quiagen, Hilden, Germany) as described previously and was reverse transcribed at 37°C for 1 h using random primer and reverse transcriptase (RT) (Superscript RT; Life Technologies, Inc., Karlsruhe, Germany). The size of the expected 738-base pair (bp) fragment of KVLQT1 was amplified by polymerase chain reaction (PCR) using the sense primer 5'-TTCTGGATGGAGATCGTG-3' and antisense primer 5'-GCCTTCCGGATGTAGATC-3' (95°C for 30 s, 63°C for 1 min, and 72°C for 1 min; 35 cycles). PCR products were visualized by loading an 8-µl sample on a 0.9% agarose gel using a 123-bp marker as a standard. The PCR product was subcloned into pBluescript SK (-) vector and sequenced using Thermo Sequenase I (Pharmacia, Freiburg, Germany) and a 373A DNA sequencer (Applied Biosystem, Norwalk, CT).

Compounds and Statistics

Amiloride and IBMX were obtained from Sigma and Merck (Deisenhofen and Darmstadt, Germany, respectively). Forskolin and 293B were obtained from Hoechst (Frankfurt/Main, Germany). All chemicals used were of highest grade of purity available. From some individuals, transepithelial measurements were performed on more than one nasal tissue. When multiple tissue samples from one individual were studied by the same experimental protocol, data were averaged to obtain a single value for each individual subject. Data are shown as individual recordings or as means ± standard error of the mean; n = number of subjects for transepithelial measurements, or n = number of experiments for WC patch-clamp studies. Statistical analysis was performed using paired Student's t test. Data obtained from CF and non-CF tissues were compared by unpaired Student's t test. A P value < 0.05 was accepted to indicate statistical significance.

    Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Expression of KVLQT1 in Airway Epithelium

Expression of KVLQT1 in respiratory epithelium was verified by isolation of RNA from mucosa of non-CF and CF nasal polyps and HBE cells. After reverse transcription and PCR, transcripts of KVLQT1 were detected in freshly isolated non-CF and CF airway epithelium as well as in HBE cells (Figure 1). Sequencing of the PCR generated a 738-bp fragment that confirmed expression of human KVLQT1.


View larger version (43K):
[in this window]
[in a new window]
 
Figure 1.   RT-PCR analysis of RNA obtained from freshly isolated CF and non-CF nasal airway epithelia and from HBE cells. A 738-bp fragment of human KVLQT1 was obtained after reverse transcription of total RNA (+) but not without RT (-). Subsequent sequencing of the amplified fragment confirmed amplification of human KVLQT1.

Contribution of Basolateral cAMP-Dependent K+ Conductance to Ion Transport in Non-CF and CF Airways

Basal properties of non-CF and CF airways were assessed. In epithelia obtained from non-CF subjects Isc was -41.5 ± 7.4 µA/cm2 (n = 16). Vte and Rte were -0.8 ± 0.1 mV and 23.9 ± 3.6 Omega cm2, respectively. Amiloride (10 µmol/liter) added to the mucosal side of the epithelium reduced Vte and Isc and increased Rte (Figures 2A and 2C). In CF, basal Vte and Isc were significantly increased (-2.3 ± 0.5 mV and -159.7 ± 31.1 µA/cm2, respectively) and basal Rte was reduced (15.9 ± 2.5 Omega cm2) when compared with non-CF subjects (n = 8). Amiloride-sensitive Isc was significantly increased in nasal tissues from CF patients (Figures 2B and 2C). When tissues from non-CF subjects were stimulated by IBMX (100 µmol/liter) and forskolin (1 µmol/ liter), both enhancing intracellular cAMP, Isc and Vte were enhanced, which was paralleled by a decrease in Rte. In CF subjects, no significant changes of Vte, Rte, or Isc were observed upon cAMP-dependent stimulation, due to the lack of luminal CFTR-Cl- channels (Figure 2C). These data demonstrate typical properties of CF and non-CF airways used in the present study.


View larger version (48K):
[in this window]
[in a new window]
 


View larger version (54K):
[in this window]
[in a new window]
 


View larger version (9K):
[in this window]
[in a new window]
 
Figure 2.   Effects of amiloride and IBMX/forskolin (IBMX/Fors) on Vte and Rte in human respiratory epithelium from non-CF (A) and CF (B) subjects. Rte was obtained from the Vte downward deflections obtained by pulsed current injection. (A) In non-CF subjects, lumen-negative Vte was reduced when amiloride (10 µmol/liter) was added to the luminal side of the epithelium. Subsequent stimulation with IBMX/forskolin (100/1 µmol/liter) induced a lumen-negative Vte, indicating activation of Cl- secretion. (B) In CF subjects, lumen-negative Vte and the effect of amiloride were both increased compared with non-CF subjects. Subsequent addition of IBMX/forskolin failed to induce Cl- secretion and thus had no effect on Vte. (C) Summary of equivalent Isc in non-CF and CF subjects under control conditions, in the presence of amiloride and IBMX/forskolin. *Statistical significance for the effects of amiloride and IBMX/forskolin (paired t test). §Statistical significance for basal properties and the effects of amiloride and IBMX/forskolin when compared with experiments obtained from non-CF tissues (unpaired t test). Number of subjects is in parentheses.

Contribution of basolateral K+ channels to cAMP-dependent Cl- secretion in human airway epithelium was assessed by using the K+ channel blockers Ba2+ and the chromanol 293B, a specific inhibitor of cAMP-activated KVLQT1 K+ channels (8, 13). In the presence of amiloride, non-CF tissues were stimulated with IBMX and forskolin (100/1 µmol/liter), which increased Isc significantly from -10.9 ± 1.6 to -36.0 ± 7.3 µA/cm2 (n = 10). Addition of 293B (10 µmol/liter) reduced cAMP-activated Isc almost completely to -16.2 ± 3.2 µA/cm2. When Ba2+ (5 mmol/ liter) was added in the presence of 293B, the remaining Isc was further reduced to -1.3 ± 2.2 µA/cm2 (n = 10) (Figures 3A and 3B). The inhibitory effect of 293B was concentration-dependent (Figure 3C) and an IC50 of approximately 0.3 µmol/liter (n = 7) was obtained (Figure 3D). This value compares well with that obtained in previous studies for human and rat colon epithelium (3, 8). In CF tissue, 293B (10 µmol/liter) had no effect on Isc in the presence of amiloride or after stimulation with IBMX/forskolin. Ba2+ (5 mmol/liter) reduced Isc from -19.4 ± 4.6 to -7.9 ± 3.1 µA/cm2 (n = 4) (Figure 3B).


View larger version (84K):
[in this window]
[in a new window]
 


View larger version (10K):
[in this window]
[in a new window]
 


View larger version (72K):
[in this window]
[in a new window]
 


View larger version (12K):
[in this window]
[in a new window]
 
Figure 3.   Effects of the chromanol 293B and Ba2+ on ion transport in respiratory epithelia from non-CF and CF subjects. (A) In non-CF tissue, in the presence of amiloride (10 µmol/liter) and IBMX/forskolin (100/1 µmol/liter), lumen-negative Vte was largely reduced by addition of 293B (10 µmol/liter). The remaining Vte was almost completely inhibited by Ba2+ (5 mmol/liter). (B) Summary of effects of 293B and Ba2+ on upper airway tissues from non-CF and CF individuals. (C) Original recording and (D) summary of the concentration dependency of the inhibitory effects of 293B obtained from respiratory epithelia from non-CF individuals. The IC50 was in the range of 0.3 µmol/liter. *Statistical significance for the effects of 293B and Ba2+ (paired t test). §Statistical significance for the effects of IBMX/forskolin and 293B when compared with experiments with tissues obtained from non-CF individuals (unpaired t test). Number of subjects is in parentheses.

We further examined the impact of cAMP-dependent stimulation on basolateral K+ conductance in strictly paired experiments. To that end, and after inhibition of the Na+ conductance by amiloride, 293B and Ba2+ were applied in the absence or presence of IBMX/forskolin. In non-CF tissue, 293B reduced Isc slightly but significantly from -19.6 ± 2.9 to -14.5 ± 2.1 µA/cm2 (n = 16) under basal conditions. The effect of 293B was completely reversible upon washout for 30 min. IBMX and forskolin increased Isc from -17.1 ± 2.5 to -44.3 ± 6.1 µA/cm2, which was reduced by 293B to -20.3 ± 2.9 µA/cm2 (Figures 4A and 5A). Thus, 293B-sensitive Isc was significantly enhanced after cAMP-dependent stimulation. Similar observations were made when the nonspecific K+ channel blocker Ba2+ (5 mmol/liter) was applied instead of 293B. In the absence of IBMX/forskolin, Ba2+ inhibited Isc by 10.9 ± 2.2 µA/cm2 (n = 10). After stimulation with IBMX and forskolin, Ba2+-sensitive Isc was significantly increased to 19.3 ± 2.4 µA/cm2, demonstrating activation of a cAMP-dependent K+ conductance (Figure 5B). In CF tissue, no significant changes were observed when 293B was added to respiratory tissues, either under control conditions or after cAMP-dependent stimulation (n = 8) (Figures 4B and 5A). As shown in Figures 3B and 5B, under control conditions the inhibitory effects of Ba2+ were comparable with that observed in non-CF tissues: Delta Isc = 16.4 ± 1.9 µA/cm2 (n = 7). However, stimulation with IBMX and forskolin did not augment Ba2+-sensitive Isc (Delta Isc = 15.4 ± 2.2 µA/cm2; n = 7) in CF tissue (Figure 5B). The data therefore clearly indicate activation of 293B-sensitive Isc in the basolateral membrane of non-CF respiratory epithelia. Due to defective CFTR Cl- channels, such an activation was not observed in epithelia from CF patients.


View larger version (52K):
[in this window]
[in a new window]
 


View larger version (37K):
[in this window]
[in a new window]
 
Figure 4.   Effects of 293B in the absence and presence of cAMP stimulation in nasal epithelia from non-CF (A) and CF (B) subjects. (A) A small but significant inhibition of lumen-negative Vte was observed in non-CF subjects under basal conditions. The effect was entirely reversible on washout for 30 min. Stimulation with IBMX and forskolin (IBMX/Fors) increased lumen-negative Vte. The effect of 293B (10 µmol/liter) was enhanced after cAMP-dependent stimulation of the tissue. (B) In CF subjects, IBMX/forskolin failed to induce Cl- secretion and 293B had no effect on epithelial transport. Experiments were performed in the presence of 10 µmol/liter amiloride.


View larger version (14K):
[in this window]
[in a new window]
 
Figure 5.   Summary of the 293B-sensitive (A) and Ba2+-sensitive (B) Isc in nasal tissues obtained from non-CF and CF subjects in the absence (open bars) or presence (filled bars) of cAMP stimulation. (A) In the presence of amiloride (10 µmol/liter), 293B- and Ba2+-sensitive Isc were significantly enhanced after incubation with IBMX and forskolin. In CF subjects, 293B- and Ba2+-sensitive Isc were not affected by cAMP-dependent stimulation. *Statistical significance for the effects of 293B and Ba2+ (paired t test). Open square indicates statistical significance for the difference of the effects of 293B and Ba2+ in the absence and presence of cAMP stimulation (paired t test). §Statistical significance for the effects of 293B when compared with experiments with nasal tissues obtained from non-CF subjects (unpaired t test). Number of subjects is in parentheses.

293B-Sensitive K+ Conductance in HBE Cells

Additional patch-clamp experiments were performed on cultured non-CF HBE cells. The WC conductance was largely increased and the cell membrane potential was depolarized by stimulation of the cells with 10 µmol/liter forskolin (Figures 6A and 6B). When extracellular Cl- concentration was reduced to 30 mmol/liter and was replaced by the impermeant anion gluconate, the WC conductance was inhibited and the membrane voltage depolarized, indicating activation of a WC Cl- conductance (Figures 6C and 6D). Next, we examined the effects of 293B on HBE cells. As shown in Figure 7A, a small but significant fraction of the WC conductance was inhibited dose-dependently by 293B after stimulation of HBE cells by 10 µmol/liter forskolin, which was paralleled by depolarization of the membrane voltage (data not shown). For 293B, an IC50 of about 6 µmol/ liter was detected. In paired experiments, the amount of WC conductance that was inhibited by 293B was significantly enhanced upon stimulation with forskolin (Figure 7A). These data indicate that 293B-sensitive K+ channels in HBE cells are activated by cAMP-dependent stimulation.


View larger version (23K):
[in this window]
[in a new window]
 
Figure 6.   Patch-clamp WC recordings in HBE cells. Continuous recording of (A) Gm and (B) membrane voltage (Vm) in HBE cells. The effects of partial replacement of extracellular Cl- by both gluconate (30Cl) and 293B (10 µmol/liter) were rather weak under control conditions and were enhanced after stimulation of the tissue with forskolin (10 µmol/liter). (C) Summary of the Gms in the absence and presence of forskolin indicating activation of a WC Cl- conductance. (D) Summary of the changes in Vm caused by forskolin and 30Cl. Forskolin depolarized Vm significantly. Depolarization of Vm was significant in the presence of forskolin, whereas no effects were observed under control conditions. *Statistical significance for the effects of 30Cl and forskolin, respectively. # Statistical significance when compared with experiments obtained under control conditions (paired t tests). Number of experiments is in parentheses.


View larger version (12K):
[in this window]
[in a new window]
 
Figure 7.   (A) Concentration dependency of the inhibitory effects of 293B on Gm in HBE cells. The IC50 of Gm was in the range of 6 µmol/liter. (B) Activation of 293B-sensitive K+ conductance by increase in intracellular cAMP. Summary of the Gms obtained in HBE cells in the presence and absence of forskolin (strictly paired experiments). *Statistical significance for the effects of 293B (paired t test). §Significant increase of Gm by forskolin (paired t test). #Statistical significance when compared with experiments obtained under control conditions (paired t test). Number of experiments is in parentheses.

    Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Transepithelial secretion of fluid, mucins, and electrolytes is essential in the formation of airway surface liquid. Cl- secretion has been shown to depend on parallel activation of luminal Cl- channels and basolateral K+ channels in various epithelia. In this secretory model, activation of a basolateral K+ conductance is indispensable for supplying the driving force for Cl- exit through the luminal membrane. The ion transport defect underlying CF airway disease is characterized by a defect of cAMP-mediated CFTR Cl- channels in the apical membrane of airway epithelia. In this study we have examined the basolateral K+ conductance that is activated during cAMP-dependent stimulation in human airway epithelial cells. To be able to assess the impact of basolateral K+ channels on cAMP-mediated Cl- secretion in native human respiratory tissue we made use of a perfused micro-Ussing chamber with an exposed area of less than 1 mm2 (22). All measurements were performed under open circuit conditions, resembling the physiologic situation in vivo and allowing for stable measurements of Vte and Rte over several hours. Due to imperfect edge-sealing, the absolute magnitude of Vte detected ex vivo was decreased compared with values reported from previous in vivo studies (23). However, transepithelial ex vivo measurements allowed to quantify cAMP-dependent Cl- secretion on the basis of equivalent Isc, and continuous bath perfusion, enabled us to investigate the basolateral K+ conductance involved in this process. It is shown here that airway Cl- secretion that is turned on by an increase of cAMP is sustained essentially by parallel activation of a basolateral K+ conductance. A previous study on murine nasal epithelia arrived at a similar conclusion (6). In this earlier report, basolateral application of the compound 293B, which inhibits KVLQT1 type K+ channels, effectively blocked cAMP-activated Isc in murine colonic epithelium but not in nasal epithelia. The authors suggested that basolateral cAMP-dependent K+ channels are different in both murine colonic and airway epithelia. In contrast to the measurements on mouse airways, the data obtained in the present study on native human respiratory tissue suggest that KVLQT1 plays a major role in maintaining cAMP-dependent Cl- secretion in human airways. In non-CF tissue, the chromanol 293B completely inhibited cAMP-stimulated Isc and reduced total Isc by about 60%. The observation that Ba2+ had an additional inhibitory effect on Isc supports the concept of different types of basolateral K+ channels contributing to airway Cl- secretion. A similar mechanism has been demonstrated for colonic epithelium of human, mouse, and rat (3, 4, 6, 24).

In the present experiments with CF respiratory tissues, activation of KVLQT1 by IBMX and forskolin failed to induce Cl- secretion. This is explained by the lack of luminal CFTR Cl- channels. Therefore, 293B had no effect in CF tissues, although KVLQT1 is expressed in human CF respiratory tissues as shown by RT-PCR analysis. Further, no evidence exists that would indicate that the level of expression of KVLQT1 in CF airways is reduced. In a study with airways from CFTR (-/-) knockout mice, however, different results were obtained. Here, cAMP-dependent stimulation induced Cl- secretion even in the airways of CF mice. This discrepancy could be explained by enhanced expression of an alternative Ca2+- dependent Cl- conductance in the luminal membrane of mouse compared with human CF airways (6, 25).

In murine nasal epithelium of both wild-type (CFTR +/+) and CFTR (-/-) knockout mice the inhibitory compound 293B was largely ineffective in blocking cAMP-activated ion secretion (6). Further, in our experiments, the IC50 values for 293B were ~ 10-fold higher in cultured HBE cells compared with native nasal tissues. Currently, there are no further data available that would explain the differences in 293B sensitivity obtained in native mouse and human airways and cultured airway cells. However, a likely explanation is that the chromanol sensitivity of KVLQT1 is modulated by additional regulatory proteins such IsK or KCNE3 (26, 27) and that these proteins are expressed differently in native tissues from different species and cultured cells. KCNE3 has recently been demonstrated to colocalize with KVLQT1 in colonic crypt cells and markedly change 293B sensitivity of the K+ currents (27).

An additional K+ conductance seems to exist in the basolateral membrane of airway epithelial cells that is blocked by Ba+ but not by 293B. Very similar observations have been made in human, mouse, and rat colonic epithelia (3, 4, 6). Although the results obtained from mouse tissue indicate the presence of Ca2+-activated K+ channels (6), there are currently no data available on human airways. The recently cloned Ca2+-activated human SK4 K+ channel would make a good candidate (10). This channel was also cloned recently from rat and was shown to be expressed in colonic epithelial cells. Further studies have to demonstrate whether this type of channel is also present in basolateral membranes of human airways. There is a large body of evidence that KVLQT1 is forming the major component of basolateral cAMP-activated K+ channels in the colonic epithelium of rat, mouse, rabbit, and human (3, 5, 6, 19, 28). The present paper now indicates for the first time that a similar mechanism is present in human airways. The presence of KVLQT1 in the basolateral membrane of human airways may challenge further research on activators of KVLQT1/IsK K+ channels (29) that could be used for the treatment of patients with CF. These activators would be particularly beneficial in conjunction with compounds that stimulate residual Cl- channel activity of mutant CFTR or that activate alternative Cl- channels present in apical membranes of CF airways (30).

    Footnotes

Abbreviations: base pair, bp; cyclic adenosine monophosphate, cAMP; cystic fibrosis, CF; CF transmembrane conductance regulator, CFTR; WC conductance, Gm; human bronchial epithelial cell line 16HBE14o-, HBE; WC current, I; isobutylmethylxanthine, IBMX; concentration for half-maximal inhibition, IC50; short-circuit current, Vte/Rte, Isc; polymerase chain reaction, PCR; reverse transcriptase, RT; transepithelial resistance, Rte; transepithelial voltage, Vte; whole cell, WC.

(Received in original form December 1, 1999 and in revised form April 26, 2000).

Acknowledgments: The authors gratefully thank Professor Laszig (ENT Clinic, University Hospital Freiburg) and Professor Münker (ENT Clinic, University Hospital Ludwigshafen) for their cooperation. The authors further acknowledge the expert technical assistance of Mrs. S. Hirtz and Mrs. C. Hodler. This work was supported by Deutsche Forschungsgemeinschaft DFG KU1228/1-1, DFG Ku 756/2-3, and Zentrum Klinische Forschung 1 (Project A2), University of Freiburg.
    References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Greger, R., and E. Schlatter. 1984. Mechanism of NaCl secretion in rectal gland tubules of spiny dogfish (Squalus acanthias): I. Experiments in isolated in vitro perfused rectal gland tubules. Pflügers Arch. 402: 63-75 [Medline].

2. Greger, R., M. Bleich, J. Leipziger, D. Ecke, M. Mall, and K. Kunzelmann. 1997. Regulation of ion transport in colonic crypts. NIPS 12: 62-66 . [Abstract/Free Full Text]

3. Mall, M., M. Bleich, R. Greger, M. Schürlein, J. Kühr, H. H. Seydewitz, M. Brandis, and K. Kunzelmann. 1998. Cholinergic dependent ion secretion in human colon requires co-activation by cAMP. Am. J. Physiol. 275: G1274-G1281 [Abstract/Free Full Text].

4. Nielsen, M. S., R. Warth, M. Bleich, B. Weyand, and R. Greger. 1998. The basolateral Ca2+-dependent K+ channel in rat colonic crypt cells. Pflügers Arch. 435: 267-272 [Medline].

5. Warth, R., N. Riedemann, M. Bleich, W. Van Driessche, A. E. Busch, and R. Greger. 1996. The cAMP-regulated and 293B-inhibited K+ conductance of rat colonic crypt base cells. Pflügers Arch. 432: 81-88 [Medline].

6. MacVinish, L. J., M. E. Hickman, D. A. Mufti, H. J. Durrington, and A. W. Cuthbert. 1998. Importance of basolateral K+ conductance in maintaining Cl- secretion in murine nasal and colonic epithelia. J. Physiol. (Lond). 510: 237-247 [Abstract/Free Full Text].

7. Devor, D. C., A. K. Singh, A. C. Gerlach, R. A. Frizzell, and R. J. Bridges. 1997. Inhibition of intestinal Cl- secretion by clotrimazole: direct effect on basolateral membrane K+ channels. Am. J. Physiol. 273: C531-C540 [Abstract/Free Full Text].

8. Lohrmann, E., I. Burhoff, R. B. Nitschke, H.-J. Lang, D. Mania, H. C. Englert, M. Hropot, R. Warth, M. Rohm, M. Bleich, and R. Greger. 1995. A new class of inhibitors of cAMP-mediated Cl- secretion in rabbit colon, acting by the reduction of cAMP-activated K+ conductance. Pflügers Arch. 429: 517-530 [Medline].

9. Lomax, R. B., G. Warhurst, and G. I. Sandle. 1996. Characteristics of two basolateral potassium channel populations in human colonic crypts. Gut 38: 243-247 [Abstract/Free Full Text].

10. Joiner, W. J., L. Y. Wang, M. D. Tang, and L. K. Kaczmarek. 1997. hSK4, a member of a novel subfamily of calcium-activated potassium channels. Proc. Natl. Acad. Sci. USA 94: 11013-11018 [Abstract/Free Full Text].

11. Warth, R., K. Hamm, M. Bleich, K. Kunzelmann, T. von Hahn, R. Schreiber, E. Ullrich, M. Mengel, N. Trautmann, P. Kindle, A. Schwab, and R. Greger. 1999. Molecular and functional characterization of the small Ca2+-regulated K+ channel (rSK4) of colonic crypts. Pflügers Arch. 438: 437-444 [Medline].

12. Devor, D. C., A. K. Singh, R. A. Frizzell, and R. J. Bridges. 1996. Modulation of Cl- secretion by benzimidazolones: I. Direct activation of a Ca2+-dependent K+ channel. Am. J. Physiol. 271: L775-L784 [Abstract/Free Full Text].

13. Bleich, M., M. Briel, A. E. Busch, H.-J. Lang, U. Gerlach, R. Greger, and K. Kunzelmann. 1997. KVLQT channels are inhibited by the K+ channel blocker 293B. Pflügers Arch. 434: 499-501 [Medline].

14. Süssbrich, H., M. Bleich, D. Ecke, M. Rizzo, S. Waldegger, F. Lang, I. Szabo, H.-J. Lang, K. Kunzelmann, R. Greger, and A. E. Busch. 1996. Specific blockade of slowly activating IsK channels by chromanols-impact on the role of IsK channels in epithelia. FEBS Lett. 396: 271-275 [Medline].

15. Neyroud, N., F. Tesson, I. Denjoy, M. Leibovici, C. Donger, J. Barhanin, S. Faure, F. Gary, P. Coumel, C. Petit, K. Schwartz, and P. Guicheney. 1997. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome [see Comments]. Nat. Genet. 15: 186-189 [Medline].

16. Sunose, H., J. Liu, and D. C. Marcus. 1997. cAMP increases K+ secretion via activation of apical IsK/KvLQT1 channels in strial marginal cells. Hear. Res. 114: 107-116 [Medline].

17. Yang, W. P., P. C. Levesque, W. A. Little, M. L. Conder, P. Ramakrishnan, M. G. Neubauer, and M. A. Blanar. 1998. Functional expression of two KvLQT1-related potassium channels responsible for an inherited idiopathic epilepsy. J. Biol. Chem. 273: 19419-19423 [Abstract/Free Full Text].

18. Kubisch, C., B. C. Schroeder, T. Friedrich, B. Lutjohann, A. El-Amraoui, S. Marlin, C. Petit, and T. J. Jentsch. 1999. KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell 96: 437-446 [Medline].

19. Hübner, M., R. Schreiber, H. Garty, R. Levy-Holzman, R. Greger, and K. Kunzelmann. 1999. Cloning and expression of KVLQT-1 from rat colon. Pflügers Arch. 437: 246 .

20. Cozens, A. L., M. J. Yezzi, K. Kunzelmann, T. Ohrui, L. Chin, K. Eng, W. E. Finkbeiner, J. H. Widdicombe, and D. C. Gruenert. 1994. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 10: 38-47 [Abstract].

21. Sakmann, B., and E. Neher. 1984. Patch clamp techniques for studying ionic channels in excitable membranes. Annu. Rev. Physiol. 46: 455-472 [Medline].

22. Mall, M., M. Bleich, R. Greger, R. Schreiber, and K. Kunzelmann. 1998. The amiloride inhibitable Na+ conductance is reduced by CFTR in normal but not in CF airways. J. Clin. Invest. 102: 15-21 [Medline].

23. Knowles, M. R., J. J. Carson, J. T. Gatzy, and R. C. Boucher. 1981. Measurements of nasal transepithelial electric potential differences in normal human subjects in vivo. Am. Rev. Respir. Dis. 124: 484-490 [Medline].

24. Sandle, G. I., C. M. McNicholas, and R. B. Lomax. 1994. Potassium channels in colonic crypts. Lancet 343: 23-25 [Medline].

25. Grubb, B. R., A. M. Paradiso, and R. C. Boucher. 1994. Anomalies in ion transport in CF mouse tracheal epithelium. Am. J. Physiol. 267: C293-C300 [Abstract/Free Full Text].

26. Sanguinetti, M. C., M. E. Curran, A. Zou, J. Shen, P. S. Spector, D. L. Atkinson, and M. T. Keating. 1996. Coassembly of KVLQT1 and minK (IsK) to form cardiac IKs potassium channel. Nature 384: 80-83 [Medline].

27. Schroeder, B. C., S. Waldegger, S. Fehr, M. Bleich, R. Warth, R. Greger, and T. J. Jentsch. 2000. A constitutional open potassium channel formed by KCNQ1 and KCNE3. Nature 403: 196-199 [Medline].

28. Süssbrich, H., M. Rizzo, S. Waldegger, F. Lang, H. J. Lang, K. Kunzelmann, D. Ecke, M. Bleich, R. Greger, and A. E. Busch. 1996. Putative physiological role of ISK channels in cAMP-mediated Cl- secretion of epithelial cells. Biophys. J. 70-2:A30. (Abstr.)

29. Abitbol, I., A. Peretz, C. Lerche, A. E. Busch, and B. Attali. 1999. Stilbenes and fenamates rescue the loss of I(KS) channel function induced by an LQT5 mutation and other IsK mutants. EMBO J. 18: 4137-4148 [Medline].

30. Kunzelmann, K.. 1999. The cystic fibrosis transmembrane conductance regulator and its function in epithelial transport. Rev. Physiol. Biochem. Pharmacol. 137: 1-70 [Medline].






This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mall, M.
Right arrow Articles by Kunzelmann, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mall, M.
Right arrow Articles by Kunzelmann, K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2000 American Thoracic Society.